Haemonetics Corporation (HAE) Free Cash Flow
Haemonetics Corporation (HAE) free cash flow history and trends. Track FCF in Excel with MarketXLS.
Free Cash Flow Data
| Period | Free Cash Flow (USD) |
|---|---|
| 2017-03-31 | $89.98M |
| 2018-03-31 | $151.56M |
| 2019-03-31 | $43.13M |
| 2020-03-31 | $126.23M |
| 2021-03-31 | $73.58M |
| 2022-03-31 | $75.75M |
| 2023-03-31 | $81.73M |
| 2024-03-31 | $143.63M |
| 2025-03-31 | $142.45M |
| 2026-03-31 | $260.44M |
How HAE compares with sector peers
| Symbol | Company | Free cash flow (latest fiscal year) |
|---|---|---|
| PODD | Insulet Corporation | $349.90M |
| MMSI | Merit Medical Systems Inc. | $212.53M |
| KRYS | Krystal Biotech Inc. | $188.91M |
| PEN | Penumbra Inc. | $174.93M |
| ARWR | Arrowhead Pharmaceuticals Inc. | $156.85M |
These are five companies in the same sector as HAE with a comparable annual free cash flow. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Haemonetics Corporation Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Free_Cash_Flow("HAE", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | HAE | $106.60 | -1.59% | 0.66M |
| 3 | ||||
| 4 | ||||
| 5 |